nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—TOP2A—Etoposide—brain cancer	0.289	0.389	CbGbCtD
Lomefloxacin—CYP1A2—Carmustine—brain cancer	0.149	0.201	CbGbCtD
Lomefloxacin—ABCC2—Carboplatin—brain cancer	0.141	0.19	CbGbCtD
Lomefloxacin—ABCC2—Etoposide—brain cancer	0.118	0.16	CbGbCtD
Lomefloxacin—CYP1A2—Etoposide—brain cancer	0.0442	0.0596	CbGbCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—S100A6—brain cancer	0.00346	0.122	CbGpPWpGaD
Lomefloxacin—TOP2A—Teniposide—Etoposide—brain cancer	0.00251	0.5	CbGdCrCtD
Lomefloxacin—TOP2A—Podofilox—Etoposide—brain cancer	0.00251	0.5	CbGdCrCtD
Lomefloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00154	0.0545	CbGpPWpGaD
Lomefloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.0014	0.0496	CbGpPWpGaD
Lomefloxacin—ABCC2—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00136	0.0479	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00129	0.0456	CbGpPWpGaD
Lomefloxacin—TOP2A—G0 and Early G1—CCNE1—brain cancer	0.000868	0.0306	CbGpPWpGaD
Lomefloxacin—Chills—Procarbazine—brain cancer	0.000814	0.00361	CcSEcCtD
Lomefloxacin—Arrhythmia—Procarbazine—brain cancer	0.00081	0.0036	CcSEcCtD
Lomefloxacin—Diplopia—Temozolomide—brain cancer	0.000793	0.00352	CcSEcCtD
Lomefloxacin—Face oedema—Carmustine—brain cancer	0.000792	0.00352	CcSEcCtD
Lomefloxacin—Tension—Procarbazine—brain cancer	0.000775	0.00344	CcSEcCtD
Lomefloxacin—Ataxia—Carmustine—brain cancer	0.000771	0.00343	CcSEcCtD
Lomefloxacin—TOP2A—G0 and Early G1—PCNA—brain cancer	0.000769	0.0271	CbGpPWpGaD
Lomefloxacin—Nervousness—Procarbazine—brain cancer	0.000767	0.00341	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000766	0.0034	CcSEcCtD
Lomefloxacin—Face oedema—Temozolomide—brain cancer	0.000765	0.0034	CcSEcCtD
Lomefloxacin—Stomatitis—Hydroxyurea—brain cancer	0.000762	0.00338	CcSEcCtD
Lomefloxacin—Ataxia—Temozolomide—brain cancer	0.000745	0.00331	CcSEcCtD
Lomefloxacin—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000741	0.0262	CbGpPWpGaD
Lomefloxacin—Tremor—Procarbazine—brain cancer	0.00074	0.00328	CcSEcCtD
Lomefloxacin—Phlebitis—Etoposide—brain cancer	0.000736	0.00327	CcSEcCtD
Lomefloxacin—Anaemia—Procarbazine—brain cancer	0.00073	0.00324	CcSEcCtD
Lomefloxacin—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000714	0.00317	CcSEcCtD
Lomefloxacin—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000713	0.0252	CbGpPWpGaD
Lomefloxacin—Dysphagia—Carmustine—brain cancer	0.000709	0.00315	CcSEcCtD
Lomefloxacin—Syncope—Procarbazine—brain cancer	0.000708	0.00314	CcSEcCtD
Lomefloxacin—Leukopenia—Procarbazine—brain cancer	0.000707	0.00314	CcSEcCtD
Lomefloxacin—Hallucination—Hydroxyurea—brain cancer	0.000698	0.0031	CcSEcCtD
Lomefloxacin—ABCC2—Irinotecan Pathway—APC—brain cancer	0.000697	0.0246	CbGpPWpGaD
Lomefloxacin—Loss of consciousness—Procarbazine—brain cancer	0.000694	0.00308	CcSEcCtD
Lomefloxacin—Cough—Procarbazine—brain cancer	0.000689	0.00306	CcSEcCtD
Lomefloxacin—Dysphagia—Temozolomide—brain cancer	0.000685	0.00304	CcSEcCtD
Lomefloxacin—Convulsion—Procarbazine—brain cancer	0.000684	0.00304	CcSEcCtD
Lomefloxacin—Hypertension—Procarbazine—brain cancer	0.000682	0.00303	CcSEcCtD
Lomefloxacin—Arthralgia—Procarbazine—brain cancer	0.000672	0.00299	CcSEcCtD
Lomefloxacin—Myalgia—Procarbazine—brain cancer	0.000672	0.00299	CcSEcCtD
Lomefloxacin—Anxiety—Procarbazine—brain cancer	0.00067	0.00297	CcSEcCtD
Lomefloxacin—Sweating increased—Temozolomide—brain cancer	0.000667	0.00296	CcSEcCtD
Lomefloxacin—Dry mouth—Procarbazine—brain cancer	0.000657	0.00292	CcSEcCtD
Lomefloxacin—Anaphylactoid reaction—Etoposide—brain cancer	0.000655	0.00291	CcSEcCtD
Lomefloxacin—Cardiac failure—Etoposide—brain cancer	0.00065	0.00289	CcSEcCtD
Lomefloxacin—Confusional state—Procarbazine—brain cancer	0.00065	0.00289	CcSEcCtD
Lomefloxacin—Vomiting—Lomustine—brain cancer	0.000645	0.00287	CcSEcCtD
Lomefloxacin—Oedema—Procarbazine—brain cancer	0.000644	0.00286	CcSEcCtD
Lomefloxacin—Dysuria—Temozolomide—brain cancer	0.000641	0.00284	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Carmustine—brain cancer	0.00064	0.00284	CcSEcCtD
Lomefloxacin—Shock—Procarbazine—brain cancer	0.000634	0.00282	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Procarbazine—brain cancer	0.000631	0.0028	CcSEcCtD
Lomefloxacin—Chills—Hydroxyurea—brain cancer	0.00063	0.0028	CcSEcCtD
Lomefloxacin—Tachycardia—Procarbazine—brain cancer	0.000629	0.00279	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Temozolomide—brain cancer	0.000625	0.00278	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Procarbazine—brain cancer	0.000623	0.00277	CcSEcCtD
Lomefloxacin—Renal failure—Carmustine—brain cancer	0.000621	0.00276	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Carmustine—brain cancer	0.00062	0.00275	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Temozolomide—brain cancer	0.000618	0.00274	CcSEcCtD
Lomefloxacin—Stomatitis—Carmustine—brain cancer	0.000616	0.00274	CcSEcCtD
Lomefloxacin—Anorexia—Procarbazine—brain cancer	0.000614	0.00273	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000606	0.00269	CcSEcCtD
Lomefloxacin—Nausea—Lomustine—brain cancer	0.000603	0.00268	CcSEcCtD
Lomefloxacin—Hypotension—Procarbazine—brain cancer	0.000602	0.00267	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Temozolomide—brain cancer	0.000599	0.00266	CcSEcCtD
Lomefloxacin—Stomatitis—Temozolomide—brain cancer	0.000595	0.00264	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000587	0.00261	CcSEcCtD
Lomefloxacin—Insomnia—Procarbazine—brain cancer	0.000583	0.00259	CcSEcCtD
Lomefloxacin—Paraesthesia—Procarbazine—brain cancer	0.000579	0.00257	CcSEcCtD
Lomefloxacin—Somnolence—Procarbazine—brain cancer	0.000573	0.00254	CcSEcCtD
Lomefloxacin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000571	0.00254	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Hydroxyurea—brain cancer	0.000567	0.00252	CcSEcCtD
Lomefloxacin—Anaemia—Hydroxyurea—brain cancer	0.000565	0.00251	CcSEcCtD
Lomefloxacin—Hallucination—Carmustine—brain cancer	0.000565	0.00251	CcSEcCtD
Lomefloxacin—Decreased appetite—Procarbazine—brain cancer	0.00056	0.00249	CcSEcCtD
Lomefloxacin—Fatigue—Procarbazine—brain cancer	0.000556	0.00247	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—APC—brain cancer	0.000556	0.0196	CbGpPWpGaD
Lomefloxacin—Malaise—Hydroxyurea—brain cancer	0.000551	0.00245	CcSEcCtD
Lomefloxacin—Constipation—Procarbazine—brain cancer	0.000551	0.00245	CcSEcCtD
Lomefloxacin—Hepatitis—Temozolomide—brain cancer	0.000548	0.00244	CcSEcCtD
Lomefloxacin—Dysphagia—Etoposide—brain cancer	0.000548	0.00243	CcSEcCtD
Lomefloxacin—Leukopenia—Hydroxyurea—brain cancer	0.000547	0.00243	CcSEcCtD
Lomefloxacin—Visual impairment—Carmustine—brain cancer	0.000547	0.00243	CcSEcCtD
Lomefloxacin—Hallucination—Temozolomide—brain cancer	0.000546	0.00242	CcSEcCtD
Lomefloxacin—Pharyngitis—Temozolomide—brain cancer	0.000544	0.00242	CcSEcCtD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—brain cancer	0.000541	0.0191	CbGpPWpGaD
Lomefloxacin—Bronchospasm—Etoposide—brain cancer	0.000539	0.00239	CcSEcCtD
Lomefloxacin—Sweating increased—Etoposide—brain cancer	0.000534	0.00237	CcSEcCtD
Lomefloxacin—Feeling abnormal—Procarbazine—brain cancer	0.000531	0.00236	CcSEcCtD
Lomefloxacin—Convulsion—Hydroxyurea—brain cancer	0.000529	0.00235	CcSEcCtD
Lomefloxacin—Visual impairment—Temozolomide—brain cancer	0.000528	0.00235	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Procarbazine—brain cancer	0.000527	0.00234	CcSEcCtD
Lomefloxacin—Flushing—Carmustine—brain cancer	0.000527	0.00234	CcSEcCtD
Lomefloxacin—Erythema multiforme—Temozolomide—brain cancer	0.000519	0.0023	CcSEcCtD
Lomefloxacin—Discomfort—Hydroxyurea—brain cancer	0.000514	0.00228	CcSEcCtD
Lomefloxacin—Urticaria—Procarbazine—brain cancer	0.000512	0.00227	CcSEcCtD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—brain cancer	0.000511	0.0181	CbGpPWpGaD
Lomefloxacin—Tinnitus—Temozolomide—brain cancer	0.000511	0.00227	CcSEcCtD
Lomefloxacin—Abdominal pain—Procarbazine—brain cancer	0.000509	0.00226	CcSEcCtD
Lomefloxacin—Flushing—Temozolomide—brain cancer	0.000509	0.00226	CcSEcCtD
Lomefloxacin—Arrhythmia—Carmustine—brain cancer	0.000507	0.00225	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—NTRK3—brain cancer	0.0005	0.0176	CbGpPWpGaD
Lomefloxacin—Oedema—Hydroxyurea—brain cancer	0.000499	0.00221	CcSEcCtD
Lomefloxacin—Chills—Temozolomide—brain cancer	0.000492	0.00219	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000488	0.00217	CcSEcCtD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000485	0.0171	CbGpPWpGaD
Lomefloxacin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000485	0.00215	CcSEcCtD
Lomefloxacin—Skin disorder—Hydroxyurea—brain cancer	0.000484	0.00215	CcSEcCtD
Lomefloxacin—Acute coronary syndrome—Etoposide—brain cancer	0.000482	0.00214	CcSEcCtD
Lomefloxacin—Renal failure—Etoposide—brain cancer	0.000481	0.00213	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Etoposide—brain cancer	0.000479	0.00213	CcSEcCtD
Lomefloxacin—Myocardial infarction—Etoposide—brain cancer	0.000479	0.00213	CcSEcCtD
Lomefloxacin—Back pain—Carmustine—brain cancer	0.000478	0.00212	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.000477	0.0168	CbGpPWpGaD
Lomefloxacin—Stomatitis—Etoposide—brain cancer	0.000476	0.00212	CcSEcCtD
Lomefloxacin—Anorexia—Hydroxyurea—brain cancer	0.000475	0.00211	CcSEcCtD
Lomefloxacin—Hypersensitivity—Procarbazine—brain cancer	0.000475	0.00211	CcSEcCtD
Lomefloxacin—Dysgeusia—Temozolomide—brain cancer	0.000467	0.00208	CcSEcCtD
Lomefloxacin—Tremor—Carmustine—brain cancer	0.000463	0.00206	CcSEcCtD
Lomefloxacin—Asthenia—Procarbazine—brain cancer	0.000462	0.00205	CcSEcCtD
Lomefloxacin—Back pain—Temozolomide—brain cancer	0.000462	0.00205	CcSEcCtD
Lomefloxacin—Anaemia—Carmustine—brain cancer	0.000457	0.00203	CcSEcCtD
Lomefloxacin—Agranulocytosis—Etoposide—brain cancer	0.000456	0.00203	CcSEcCtD
Lomefloxacin—Pruritus—Procarbazine—brain cancer	0.000456	0.00202	CcSEcCtD
Lomefloxacin—Agitation—Carmustine—brain cancer	0.000454	0.00202	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000448	0.0158	CbGpPWpGaD
Lomefloxacin—Tremor—Temozolomide—brain cancer	0.000447	0.00199	CcSEcCtD
Lomefloxacin—Dyspnoea—Hydroxyurea—brain cancer	0.000445	0.00197	CcSEcCtD
Lomefloxacin—Somnolence—Hydroxyurea—brain cancer	0.000443	0.00197	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Temozolomide—brain cancer	0.000443	0.00197	CcSEcCtD
Lomefloxacin—Leukopenia—Carmustine—brain cancer	0.000442	0.00196	CcSEcCtD
Lomefloxacin—Anaemia—Temozolomide—brain cancer	0.000441	0.00196	CcSEcCtD
Lomefloxacin—Diarrhoea—Procarbazine—brain cancer	0.000441	0.00196	CcSEcCtD
Lomefloxacin—Dyspepsia—Hydroxyurea—brain cancer	0.000439	0.00195	CcSEcCtD
Lomefloxacin—Agitation—Temozolomide—brain cancer	0.000439	0.00195	CcSEcCtD
Lomefloxacin—Angioedema—Temozolomide—brain cancer	0.000436	0.00194	CcSEcCtD
Lomefloxacin—Decreased appetite—Hydroxyurea—brain cancer	0.000434	0.00193	CcSEcCtD
Lomefloxacin—Malaise—Temozolomide—brain cancer	0.00043	0.00191	CcSEcCtD
Lomefloxacin—Fatigue—Hydroxyurea—brain cancer	0.00043	0.00191	CcSEcCtD
Lomefloxacin—Vertigo—Temozolomide—brain cancer	0.000429	0.0019	CcSEcCtD
Lomefloxacin—Convulsion—Carmustine—brain cancer	0.000428	0.0019	CcSEcCtD
Lomefloxacin—Leukopenia—Temozolomide—brain cancer	0.000427	0.0019	CcSEcCtD
Lomefloxacin—Hypertension—Carmustine—brain cancer	0.000426	0.00189	CcSEcCtD
Lomefloxacin—Constipation—Hydroxyurea—brain cancer	0.000426	0.00189	CcSEcCtD
Lomefloxacin—Dizziness—Procarbazine—brain cancer	0.000426	0.00189	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000425	0.015	CbGpPWpGaD
Lomefloxacin—Myalgia—Carmustine—brain cancer	0.000421	0.00187	CcSEcCtD
Lomefloxacin—Chest pain—Carmustine—brain cancer	0.000421	0.00187	CcSEcCtD
Lomefloxacin—Anxiety—Carmustine—brain cancer	0.000419	0.00186	CcSEcCtD
Lomefloxacin—Cough—Temozolomide—brain cancer	0.000417	0.00185	CcSEcCtD
Lomefloxacin—Erythema multiforme—Etoposide—brain cancer	0.000415	0.00184	CcSEcCtD
Lomefloxacin—Convulsion—Temozolomide—brain cancer	0.000414	0.00184	CcSEcCtD
Lomefloxacin—Hypertension—Temozolomide—brain cancer	0.000412	0.00183	CcSEcCtD
Lomefloxacin—Feeling abnormal—Hydroxyurea—brain cancer	0.000411	0.00182	CcSEcCtD
Lomefloxacin—Vomiting—Procarbazine—brain cancer	0.00041	0.00182	CcSEcCtD
Lomefloxacin—Flushing—Etoposide—brain cancer	0.000407	0.00181	CcSEcCtD
Lomefloxacin—Confusional state—Carmustine—brain cancer	0.000407	0.00181	CcSEcCtD
Lomefloxacin—Arthralgia—Temozolomide—brain cancer	0.000406	0.0018	CcSEcCtD
Lomefloxacin—Myalgia—Temozolomide—brain cancer	0.000406	0.0018	CcSEcCtD
Lomefloxacin—Rash—Procarbazine—brain cancer	0.000406	0.0018	CcSEcCtD
Lomefloxacin—Dermatitis—Procarbazine—brain cancer	0.000406	0.0018	CcSEcCtD
Lomefloxacin—Anxiety—Temozolomide—brain cancer	0.000405	0.0018	CcSEcCtD
Lomefloxacin—Headache—Procarbazine—brain cancer	0.000404	0.00179	CcSEcCtD
Lomefloxacin—Oedema—Carmustine—brain cancer	0.000403	0.00179	CcSEcCtD
Lomefloxacin—Discomfort—Temozolomide—brain cancer	0.000402	0.00178	CcSEcCtD
Lomefloxacin—Dry mouth—Temozolomide—brain cancer	0.000397	0.00177	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Carmustine—brain cancer	0.000395	0.00175	CcSEcCtD
Lomefloxacin—Chills—Etoposide—brain cancer	0.000394	0.00175	CcSEcCtD
Lomefloxacin—Tachycardia—Carmustine—brain cancer	0.000393	0.00175	CcSEcCtD
Lomefloxacin—Confusional state—Temozolomide—brain cancer	0.000393	0.00174	CcSEcCtD
Lomefloxacin—Oedema—Temozolomide—brain cancer	0.00039	0.00173	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Temozolomide—brain cancer	0.00039	0.00173	CcSEcCtD
Lomefloxacin—Anorexia—Carmustine—brain cancer	0.000384	0.00171	CcSEcCtD
Lomefloxacin—Nausea—Procarbazine—brain cancer	0.000383	0.0017	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Temozolomide—brain cancer	0.000381	0.00169	CcSEcCtD
Lomefloxacin—Skin disorder—Temozolomide—brain cancer	0.000378	0.00168	CcSEcCtD
Lomefloxacin—Hypotension—Carmustine—brain cancer	0.000377	0.00167	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Temozolomide—brain cancer	0.000377	0.00167	CcSEcCtD
Lomefloxacin—Dysgeusia—Etoposide—brain cancer	0.000374	0.00166	CcSEcCtD
Lomefloxacin—Anorexia—Temozolomide—brain cancer	0.000371	0.00165	CcSEcCtD
Lomefloxacin—Back pain—Etoposide—brain cancer	0.00037	0.00164	CcSEcCtD
Lomefloxacin—Hypersensitivity—Hydroxyurea—brain cancer	0.000367	0.00163	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000367	0.00163	CcSEcCtD
Lomefloxacin—Muscle spasms—Etoposide—brain cancer	0.000367	0.00163	CcSEcCtD
Lomefloxacin—Insomnia—Carmustine—brain cancer	0.000365	0.00162	CcSEcCtD
Lomefloxacin—Paraesthesia—Carmustine—brain cancer	0.000362	0.00161	CcSEcCtD
Lomefloxacin—Dyspnoea—Carmustine—brain cancer	0.000359	0.0016	CcSEcCtD
Lomefloxacin—Somnolence—Carmustine—brain cancer	0.000358	0.00159	CcSEcCtD
Lomefloxacin—Asthenia—Hydroxyurea—brain cancer	0.000358	0.00159	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—brain cancer	0.000358	0.0126	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000356	0.0126	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000355	0.00158	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Etoposide—brain cancer	0.000354	0.00157	CcSEcCtD
Lomefloxacin—Anaemia—Etoposide—brain cancer	0.000353	0.00157	CcSEcCtD
Lomefloxacin—Insomnia—Temozolomide—brain cancer	0.000352	0.00156	CcSEcCtD
Lomefloxacin—Decreased appetite—Carmustine—brain cancer	0.00035	0.00156	CcSEcCtD
Lomefloxacin—Paraesthesia—Temozolomide—brain cancer	0.00035	0.00155	CcSEcCtD
Lomefloxacin—Dyspnoea—Temozolomide—brain cancer	0.000347	0.00154	CcSEcCtD
Lomefloxacin—Somnolence—Temozolomide—brain cancer	0.000346	0.00154	CcSEcCtD
Lomefloxacin—Constipation—Carmustine—brain cancer	0.000345	0.00153	CcSEcCtD
Lomefloxacin—Malaise—Etoposide—brain cancer	0.000344	0.00153	CcSEcCtD
Lomefloxacin—Vertigo—Etoposide—brain cancer	0.000343	0.00152	CcSEcCtD
Lomefloxacin—Dyspepsia—Temozolomide—brain cancer	0.000343	0.00152	CcSEcCtD
Lomefloxacin—Leukopenia—Etoposide—brain cancer	0.000342	0.00152	CcSEcCtD
Lomefloxacin—Diarrhoea—Hydroxyurea—brain cancer	0.000341	0.00152	CcSEcCtD
Lomefloxacin—Decreased appetite—Temozolomide—brain cancer	0.000339	0.0015	CcSEcCtD
Lomefloxacin—Fatigue—Temozolomide—brain cancer	0.000336	0.00149	CcSEcCtD
Lomefloxacin—Loss of consciousness—Etoposide—brain cancer	0.000336	0.00149	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—SKP2—brain cancer	0.000335	0.0118	CbGpPWpGaD
Lomefloxacin—Cough—Etoposide—brain cancer	0.000333	0.00148	CcSEcCtD
Lomefloxacin—Constipation—Temozolomide—brain cancer	0.000333	0.00148	CcSEcCtD
Lomefloxacin—Feeling abnormal—Carmustine—brain cancer	0.000332	0.00148	CcSEcCtD
Lomefloxacin—Convulsion—Etoposide—brain cancer	0.000331	0.00147	CcSEcCtD
Lomefloxacin—Hypertension—Etoposide—brain cancer	0.00033	0.00146	CcSEcCtD
Lomefloxacin—Dizziness—Hydroxyurea—brain cancer	0.00033	0.00146	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Carmustine—brain cancer	0.00033	0.00146	CcSEcCtD
Lomefloxacin—Chest pain—Etoposide—brain cancer	0.000325	0.00144	CcSEcCtD
Lomefloxacin—Discomfort—Etoposide—brain cancer	0.000321	0.00143	CcSEcCtD
Lomefloxacin—Feeling abnormal—Temozolomide—brain cancer	0.000321	0.00143	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.00032	0.0113	CbGpPWpGaD
Lomefloxacin—Abdominal pain—Carmustine—brain cancer	0.000319	0.00142	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Temozolomide—brain cancer	0.000319	0.00141	CcSEcCtD
Lomefloxacin—Vomiting—Hydroxyurea—brain cancer	0.000317	0.00141	CcSEcCtD
Lomefloxacin—Rash—Hydroxyurea—brain cancer	0.000314	0.0014	CcSEcCtD
Lomefloxacin—Confusional state—Etoposide—brain cancer	0.000314	0.0014	CcSEcCtD
Lomefloxacin—Dermatitis—Hydroxyurea—brain cancer	0.000314	0.0014	CcSEcCtD
Lomefloxacin—Headache—Hydroxyurea—brain cancer	0.000312	0.00139	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Etoposide—brain cancer	0.000312	0.00138	CcSEcCtD
Lomefloxacin—Urticaria—Temozolomide—brain cancer	0.00031	0.00137	CcSEcCtD
Lomefloxacin—Abdominal pain—Temozolomide—brain cancer	0.000308	0.00137	CcSEcCtD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000308	0.0109	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—brain cancer	0.000307	0.0108	CbGpPWpGaD
Lomefloxacin—Thrombocytopenia—Etoposide—brain cancer	0.000305	0.00136	CcSEcCtD
Lomefloxacin—Tachycardia—Etoposide—brain cancer	0.000304	0.00135	CcSEcCtD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000304	0.0107	CbGpPWpGaD
Lomefloxacin—Skin disorder—Etoposide—brain cancer	0.000303	0.00134	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Etoposide—brain cancer	0.000301	0.00134	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000299	0.0106	CbGpPWpGaD
Lomefloxacin—Anorexia—Etoposide—brain cancer	0.000297	0.00132	CcSEcCtD
Lomefloxacin—Hypersensitivity—Carmustine—brain cancer	0.000297	0.00132	CcSEcCtD
Lomefloxacin—Nausea—Hydroxyurea—brain cancer	0.000296	0.00132	CcSEcCtD
Lomefloxacin—Hypotension—Etoposide—brain cancer	0.000291	0.00129	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—MYC—brain cancer	0.00029	0.0102	CbGpPWpGaD
Lomefloxacin—Asthenia—Carmustine—brain cancer	0.000289	0.00128	CcSEcCtD
Lomefloxacin—Hypersensitivity—Temozolomide—brain cancer	0.000287	0.00127	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000284	0.01	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—EGFR—brain cancer	0.000283	0.01	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Etoposide—brain cancer	0.00028	0.00124	CcSEcCtD
Lomefloxacin—Asthenia—Temozolomide—brain cancer	0.00028	0.00124	CcSEcCtD
Lomefloxacin—Dyspnoea—Etoposide—brain cancer	0.000278	0.00123	CcSEcCtD
Lomefloxacin—Somnolence—Etoposide—brain cancer	0.000277	0.00123	CcSEcCtD
Lomefloxacin—Diarrhoea—Carmustine—brain cancer	0.000276	0.00122	CcSEcCtD
Lomefloxacin—Pruritus—Temozolomide—brain cancer	0.000276	0.00122	CcSEcCtD
Lomefloxacin—Decreased appetite—Etoposide—brain cancer	0.000271	0.0012	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000271	0.00957	CbGpPWpGaD
Lomefloxacin—Fatigue—Etoposide—brain cancer	0.000269	0.00119	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000268	0.00946	CbGpPWpGaD
Lomefloxacin—Dizziness—Carmustine—brain cancer	0.000267	0.00118	CcSEcCtD
Lomefloxacin—Constipation—Etoposide—brain cancer	0.000267	0.00118	CcSEcCtD
Lomefloxacin—Diarrhoea—Temozolomide—brain cancer	0.000267	0.00118	CcSEcCtD
Lomefloxacin—Dizziness—Temozolomide—brain cancer	0.000258	0.00114	CcSEcCtD
Lomefloxacin—Feeling abnormal—Etoposide—brain cancer	0.000257	0.00114	CcSEcCtD
Lomefloxacin—Vomiting—Carmustine—brain cancer	0.000256	0.00114	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Etoposide—brain cancer	0.000255	0.00113	CcSEcCtD
Lomefloxacin—Rash—Carmustine—brain cancer	0.000254	0.00113	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000254	0.00897	CbGpPWpGaD
Lomefloxacin—Dermatitis—Carmustine—brain cancer	0.000254	0.00113	CcSEcCtD
Lomefloxacin—Headache—Carmustine—brain cancer	0.000253	0.00112	CcSEcCtD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00025	0.00881	CbGpPWpGaD
Lomefloxacin—Vomiting—Temozolomide—brain cancer	0.000248	0.0011	CcSEcCtD
Lomefloxacin—Urticaria—Etoposide—brain cancer	0.000248	0.0011	CcSEcCtD
Lomefloxacin—Abdominal pain—Etoposide—brain cancer	0.000246	0.00109	CcSEcCtD
Lomefloxacin—Rash—Temozolomide—brain cancer	0.000246	0.00109	CcSEcCtD
Lomefloxacin—Dermatitis—Temozolomide—brain cancer	0.000245	0.00109	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000245	0.00865	CbGpPWpGaD
Lomefloxacin—Headache—Temozolomide—brain cancer	0.000244	0.00108	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—PPP1R12A—brain cancer	0.000242	0.00855	CbGpPWpGaD
Lomefloxacin—Nausea—Carmustine—brain cancer	0.000239	0.00106	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—TP53—brain cancer	0.000238	0.0084	CbGpPWpGaD
Lomefloxacin—Nausea—Temozolomide—brain cancer	0.000231	0.00103	CcSEcCtD
Lomefloxacin—Hypersensitivity—Etoposide—brain cancer	0.00023	0.00102	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000225	0.00795	CbGpPWpGaD
Lomefloxacin—Asthenia—Etoposide—brain cancer	0.000224	0.000993	CcSEcCtD
Lomefloxacin—Pruritus—Etoposide—brain cancer	0.000221	0.000979	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000215	0.00757	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Etoposide—brain cancer	0.000213	0.000947	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000213	0.00752	CbGpPWpGaD
Lomefloxacin—Dizziness—Etoposide—brain cancer	0.000206	0.000915	CcSEcCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000199	0.00704	CbGpPWpGaD
Lomefloxacin—Vomiting—Etoposide—brain cancer	0.000198	0.00088	CcSEcCtD
Lomefloxacin—Rash—Etoposide—brain cancer	0.000197	0.000873	CcSEcCtD
Lomefloxacin—Dermatitis—Etoposide—brain cancer	0.000196	0.000872	CcSEcCtD
Lomefloxacin—Headache—Etoposide—brain cancer	0.000195	0.000867	CcSEcCtD
Lomefloxacin—Nausea—Etoposide—brain cancer	0.000185	0.000822	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000176	0.00622	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000173	0.0061	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—brain cancer	0.000172	0.00609	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000171	0.00602	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—SIRT1—brain cancer	0.000166	0.00585	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000164	0.0058	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000159	0.0056	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000158	0.00559	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000156	0.00549	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000151	0.00534	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000137	0.00483	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000133	0.00468	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000132	0.00465	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000131	0.00462	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000131	0.00461	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000127	0.00448	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—CDK4—brain cancer	0.000125	0.00443	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—brain cancer	0.000123	0.00434	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000123	0.00434	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000111	0.00393	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—SKP2—brain cancer	0.00011	0.00388	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—brain cancer	0.00011	0.00387	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000104	0.00368	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	9.83e-05	0.00347	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDK6—brain cancer	9.8e-05	0.00346	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.55e-05	0.00337	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—brain cancer	8.93e-05	0.00315	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.44e-05	0.00298	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.35e-05	0.00295	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—brain cancer	8.26e-05	0.00292	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	7.89e-05	0.00279	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BRCA2—brain cancer	7.62e-05	0.00269	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCNE1—brain cancer	7.38e-05	0.00261	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.35e-05	0.0026	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PCNA—brain cancer	7.32e-05	0.00258	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	7.19e-05	0.00254	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	7.11e-05	0.00251	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.77e-05	0.00239	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.62e-05	0.00234	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PCNA—brain cancer	6.54e-05	0.00231	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—brain cancer	6.32e-05	0.00223	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	6.04e-05	0.00213	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDK4—brain cancer	5.65e-05	0.002	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.56e-05	0.00196	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	5.56e-05	0.00196	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	5.43e-05	0.00192	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	5.43e-05	0.00192	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—brain cancer	5.33e-05	0.00188	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	5.09e-05	0.0018	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—brain cancer	4.83e-05	0.00171	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2A—brain cancer	4.32e-05	0.00153	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—brain cancer	4.08e-05	0.00144	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.72e-05	0.00131	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND1—brain cancer	3.65e-05	0.00129	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—brain cancer	3.28e-05	0.00116	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MYC—brain cancer	2.93e-05	0.00103	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TP53—brain cancer	2.41e-05	0.000849	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2C9—brain cancer	2.27e-05	0.0008	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BSG—brain cancer	1.93e-05	0.000681	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—IDH1—brain cancer	1.66e-05	0.000585	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.35e-05	0.000477	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ENO2—brain cancer	1.31e-05	0.000463	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CG—brain cancer	6.01e-06	0.000212	CbGpPWpGaD
